Consensus Boston Scientific Corporation

Equities

BSX

US1011371077

Advanced Medical Equipment & Technology

Real-time Estimate Cboe BZX Other stock markets 15:58:13 04/12/2024 GMT			5-day change	1st Jan Change
91.17 ^USD	+0.77%		+0.40%	+57.60%

11-25	Boston Scientific to Buy Intera Oncology	MT
11-25	Boston Scientific Corporation has entered into a definitive agreement to acquire Intera Oncology Inc.	CI

Evolution of the Average Target: Boston Scientific Corporation

average-target-price-chart BOSTON-SCIENTIFIC-CORPORA

Evolution of the Target Price: Boston Scientific Corporation

target-price-consensus-chart BOSTON-SCIENTIFIC-CORPORA

Changes in Analyst Recommendations: Boston Scientific Corporation

1f66fd99213208e6dd42153db39.et15lkOKOZhQ8Pdbs1eTZiwV_DmPIkcXttPjYzflfQk.TolP-DS9TKk3g4EdyRXML05QtlTLExdbhIamJnCUDmxLihynOftw6Beypg~6eb41930432d2aef02ab902dbc23a211

Analysts' recommendations: Boston Scientific Corporation

Daiwa Securities Adjusts Price Target on Boston Scientific to $94 From $83, Maintains Buy Rating	10-28	MT
Redburn Atlantic Adjusts Price Target on Boston Scientific to $95 From $85	10-25	MT
Argus Adjusts Price Target on Boston Scientific to $105 From $90	10-25	MT
Oppenheimer Adjusts Price Target on Boston Scientific to $90 From $85, Maintains Market Perform	10-24	MT
UBS Adjusts Price Target on Boston Scientific to $102 From $94, Maintains Buy Rating	10-24	MT
Mizuho Adjusts Price Target on Boston Scientific to $110 From $100	10-24	MT
CL King Adjusts Price Target on Boston Scientific to $100 From $90	10-24	MT
Deutsche Bank Adjusts Price Target on Boston Scientific to $87 From $78, Maintains Hold Rating	10-24	MT
Bernstein Adjusts Price Target on Boston Scientific to $100 From $92, Maintains Outperform Rating	10-24	MT
Wolfe Research Adjusts Price Target on Boston Scientific to $95 From $84, Maintains Outperform Rating	10-24	MT
Raymond James Adjusts Price Target on Boston Scientific to $101 From $94, Maintains Strong Buy Rating	10-24	MT
Goldman Sachs Adjusts Price Target on Boston Scientific to $102 From $95, Maintains Buy Rating	10-24	MT
Jefferies Adjusts Price Target on Boston Scientific to $100 From $90, Maintains Buy Rating	10-24	MT
JPMorgan Adjusts Price Target on Boston Scientific to $100 From $85, Maintains Overweight Rating	10-24	MT
Wells Fargo Adjusts Price Target on Boston Scientific to $98 From $87, Maintains Overweight Rating	10-24	MT
RBC Raises Price Target on Boston Scientific to $98 From $95, Keeps Outperform Rating	10-24	MT
BTIG Raises Boston Scientific's Price Target to $97 From $93	10-23	MT
Morgan Stanley Raises Boston Scientific's Price Target to $100 From $92	10-23	MT
Citigroup Adjusts Boston Scientific's Price Target to $98 From $92, Keeps Buy Rating	10-23	MT
Evercore ISI Adjusts Price Target on Boston Scientific to $95 From $90, Maintains Outperform Rating	10-23	MT
Piper Sandler Adjusts Price Target on Boston Scientific to $95 From $90	10-23	MT
TD Cowen Adjusts Price Target on Boston Scientific to $100 From $86	10-21	MT
Stifel Adjusts Price Target on Boston Scientific to $100 From $85, Maintains Buy Rating	10-18	MT
Needham Downgrades Boston Scientific to Hold From Buy	10-18	MT
Baird Adjusts Price Target on Boston Scientific to $100 From $91	10-15	MT

More recommendations

Sector Comparison:

	Add to a list Add to a list 0 selected To use this feature you must be a member Log in Sign up	Analyst Opinion	4m Revision of opinion	Divergence of analysts' opinions	Divergence of Target Price	Ecart obj. / dr
	BOSTON SCIENTIFIC CORPORATION					+7.22%
	THERMO FISHER SCIENTIFIC INC.					+22.36%
	INTUITIVE SURGICAL, INC.					-0.07%
	DANAHER CORPORATION					+20.45%
	SIEMENS HEALTHINEERS AG					+15.31%
	SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.					+35.32%
	EDWARDS LIFESCIENCES CORPORATION					+9.41%
	AGILENT TECHNOLOGIES, INC.					+6.72%
	GE HEALTHCARE TECHNOLOGIES INC.					+17.24%
	RESMED, INC.					+2.63%
	Average					+13.66%
	Weighted average by Cap.					+13.43%

See all sector consensus

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

90.47USD

Average target price

97.00USD

Spread / Average Target

+7.22%

High Price Target

110.00USD

Spread / Highest target

+21.59%

Low Price Target

83.00USD

Spread / Lowest Target

-8.26%

Analyst Consensus Detail

consensus-detail-chart BOSTON-SCIENTIFIC-CORPORA

Consensus revision (last 18 months)

consensus-revision-chart BOSTON-SCIENTIFIC-CORPORA

Analysts covering the company

Daiwa Securities
Redburn Atlantic
Argus
Oppenheimer
UBS
Mizuho Securities
Deutsche Bank Securities
Wells Fargo Securities
JPMorgan Chase
Jefferies & Co.
Goldman Sachs
Raymond James
Wolfe Research
Bernstein
CL King
RBC Capital Markets
BTIG
Morgan Stanley
Citigroup
Evercore ISI
Piper Sandler
TD Cowen
Stifel Nicolaus
Needham & Co.
Baird
Truist Securities
Canaccord Genuity
Barclays
Nephron Research
BofA Securities
SVB Leerink
Credit Suisse
Atlantic Equities